Denna webbsida är endast avsedd för läkare och sjukvårdspersonal med förskrivningsrätt.

Neoadjuvant Immunotherapy in NSCLC – Surgical Perspectives

‭‬‬‬‬‬‬‬‬TEAMS MEETING ‬‬‬
21 november kl 18.30 – 20.00

Bristol Myers Squibb would like to invite you to a digital educational meeting to learn more about considerations for surgery after immunotherapy in lung cancer.

Thoracic Surgeon and Professor Jonathan Spicer, McGill University, Canada, will share his experiences and discuss scientific data on neoadjuvant immunotherapy in NSCLC.

Dr. Jussi Koivunen; Associate Professor of Oncology at Oulu University Hospital, Finland, will moderate the discussion.

Warm welcome

The Nordic Thoracic oncology team at BMS


18:30 – 18:40 Introductions and Opening remarks. Dr. Jussi Koivunen
18:40 – 19:40 What about surgery after immunotherapy? Prof. Jonathan Spicer
19:40 – 20:00 Questions & Discussion. All

Online registration is open until 20 November 2023

För mer information och anmälan